Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Transcode Therapeutics, Inc. (RNAZ)

TransCode Therapeutics prepays $840,975 on convertible notes after Floor Price breaches

Negative Impact 3 of 5 financing Written later

On October 1, 2026, TransCode Therapeutics made an $840,975 prepayment on its convertible notes with Yorkville under a waiver. The stock's daily VWAP was below the $1.72 Floor Price on 10 of 14 trading days from September 11 to September 30, 2026, which could have triggered monthly repayment obligations. After the prepayment, about $4.1 million of principal remains outstanding, and the waiver covers potential Amortization Events through October 31, 2026.

Key points

  • Prepayment of $840,975 made October 1, 2026: $759,000 principal, $75,900 prepayment premium and $6,075 accrued interest.
  • Yorkville waived any Amortization Event deemed to have occurred through September 30, 2026, and through October 31, 2026.
  • Daily VWAP was below the $1.72 Floor Price on 10 of 14 trading days from September 11 to September 30, 2026.
  • About $4.1 million of principal remains under the Convertible Notes after the prepayment.

The filing

CompanyTranscode Therapeutics, Inc. (RNAZ)
Form8-K, current report
Filed with the SECOct 1, 2026, 4:05 PM ET
Accession number0001104659-26-112826

Items reported: 1.01 Material Definitive Agreement2.04 Obligation Accelerated

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.